NCT06989931

Brief Summary

The study objective is to evaluate the safety and effectiveness of Intracranial Distal Access Catheter in neurointerventional therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 7, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 15, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 25, 2025

Completed
Last Updated

May 25, 2025

Status Verified

May 1, 2025

Enrollment Period

3 months

First QC Date

April 15, 2025

Last Update Submit

May 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Technical success rate

    It is defined as the proportion of subjects where Intracranial Distal Access Catheter can reach the expected position to successfully deliver the device and meet the treatment needs. Special note: If the patient uses more than one Intracranial Distal Access Catheters during the procedure, as long as any Intracranial Distal Access Catheter is delivered successfully, the patient is considered to achieve successful delivery with Intracranial Distal Access Catheter. Technical success rate (%) = number of patients successfully delivered/number of patients analyzed \* 100%

    immediately after procedure

Secondary Outcomes (3)

  • Catheter delivery success rate

    immediately after procedure

  • Incidence of device-related adverse events

    from the procedure to patients discharged from the hospital, anticipated average 5 days

  • Incidence of device-related serious adverse events

    from the procedure to patients discharged from the hospital, anticipated average 5 days

Other Outcomes (3)

  • Device operation performance (device compatibility)

    intra-procedure

  • Device operation performance (supporting capability)

    intra-procedure

  • Device operation performance (pushing resistance)

    intra-procedure

Study Arms (1)

Subjects who using the Intracranial Distal Access Catheter to complete the procedure

Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter to complete the procedure (such as poor vascular access conditions, lesions located in secondary or higher branches of cerebral vessels, inability of conventional guiding catheters in place and providing effective support. Treatment with Flow-divert devices, covered stents, etc.)

Device: Intracranial Distal Access Catheter

Interventions

Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter(X-Track) to complete the procedure

Subjects who using the Intracranial Distal Access Catheter to complete the procedure

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter to complete the procedure (such as poor vascular access conditions, lesions located in secondary or higher branches of cerebral vessels, inability of conventional guiding catheters in place and providing effective support. Treatment with Flow-divert devices, covered stents, stent grafts, etc.)

You may qualify if:

  • Age = 18-80 years old.
  • Patients with mechanical thrombectomy for acute ischemic stroke, treatment of intracranial aneurysms and other ischemic and hemorrhagic diseases, requiring the use of Intracranial Distal Access Catheter to complete the procedure (such as poor vascular access conditions, lesions located in secondary or higher branches of cerebral vessels, inability of conventional guiding catheters in place and providing effective support. Treatment with Flow-divert devices, covered stents, stent grafts, etc.)
  • Patients agree to participate in the study and sign the informed consent form.(only prospective enrolled patients)

You may not qualify if:

  • Intracranial Distal Access Catheter is used during the interventional therapy of non-neurovascular diseases, such as peripheral vascular and coronary artery diseases.
  • Interventional procedure is performed with other distal catheters or devices with the same function before using Intracranial Distal Access Catheter.
  • Ordinary guiding catheters can be used to establish access to complete the procedure without the use of Intracranial Distal Access Catheter.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Zhangzhou Municipal Hospital of Fujian Province

Zhangzhou, Fujian, China

Location

Jiangmen Xinhui District People's Hospital

Jiangmen, Guangdong, China

Location

Xinxiang Central Hospital

Xinxiang, Henan, China

Location

The Sixth People's Hospital of Nantong

Nantong, Jiangsu, China

Location

People's Hospital of Rizhao

Rizhao, Shandong, China

Location

The Affiliated Hospital of Yunnan University

Kunming, Yunnan, China

Location

MeSH Terms

Conditions

Ischemic StrokeIntracranial Aneurysm

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesIntracranial Arterial DiseasesAneurysm

Study Officials

  • JUN DONG, Associate chief physician

    Rizhao People's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2025

First Posted

May 25, 2025

Study Start

December 7, 2023

Primary Completion

March 1, 2024

Study Completion

March 1, 2024

Last Updated

May 25, 2025

Record last verified: 2025-05

Locations